Literature DB >> 19826768

Multifocal signal modulation therapy of cancer: ancient weapon, modern targets.

Tanya Das1, Gaurisankar Sa, Baisakhi Saha, Kaushik Das.   

Abstract

Although safe in most cases, ancient treatments are ignored because neither their active components nor their molecular targets are well defined. This is not the case, however, with curcumin, a yellow-pigment substance and component of turmeric (Curcuma longa), which was identified more than a century ago. Recently, extensive research has addressed the chemotherapeutic potential of this relatively nontoxic-plant-derived polyphenol. Because most cancers are caused by deregulation of as many as 500 different genes, agents that target multiple gene products are needed for prevention and treatment of cancer. In this regard, curcumin has been reported to have immense potentiality for being used in cancer chemotherapy because of its control over the machineries of cell survival, proliferation, invasion, and angiogenesis. The mechanisms implicated are diverse and appear to involve a combination of cell signaling pathways at multiple levels. This review seeks to summarize the unique multifocal signal modulatory properties of the "ancient weapon," curcumin, which may be exploited for successful clinical cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826768     DOI: 10.1007/s11010-009-0269-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  87 in total

1.  Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines.

Authors:  Shahar Lev-Ari; Yair Maimon; Ludmila Strier; Dina Kazanov; Nadir Arber
Journal:  J Soc Integr Oncol       Date:  2006

2.  Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B.

Authors:  R Mohan; J Sivak; P Ashton; L A Russo; B Q Pham; N Kasahara; M B Raizman; M E Fini
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

3.  c-Abl kinase regulates curcumin-induced cell death through activation of c-Jun N-terminal kinase.

Authors:  Ravindra Kamath; Zhihua Jiang; Guoming Sun; Jack C Yalowich; R Baskaran
Journal:  Mol Pharmacol       Date:  2006-10-04       Impact factor: 4.436

Review 4.  Endocrinology in cancer of the breast. Status and prospects.

Authors:  M J Brennan
Journal:  Am J Clin Pathol       Date:  1975-12       Impact factor: 2.493

5.  Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway.

Authors:  Sudip Sen; Himani Sharma; Neeta Singh
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

6.  Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

Authors:  Beatrice E Bachmeier; Isabelle V Mohrenz; Valentina Mirisola; Erwin Schleicher; Francesco Romeo; Clara Höhneke; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Carcinogenesis       Date:  2007-11-13       Impact factor: 4.944

7.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

Authors:  T Kawamori; R Lubet; V E Steele; G J Kelloff; R B Kaskey; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

8.  Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody.

Authors:  Anil Shanker; Alan David Brooks; Carlos Alberto Tristan; John William Wine; Peter John Elliott; Hideo Yagita; Kazuyoshi Takeda; Mark John Smyth; William Joseph Murphy; Thomas Joseph Sayers
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

9.  GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.

Authors:  Tanya Das; Gaurisankar Sa; Cynthia Hilston; Daisuke Kudo; Patricia Rayman; Kaushik Biswas; Luis Molto; Ronald Bukowski; Brian Rini; James H Finke; Charles Tannenbaum
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 10.  Antitumor, anti-invasion, and antimetastatic effects of curcumin.

Authors:  Girija Kuttan; Kuzhuvelil B Hari Kumar; Chandrasekharan Guruvayoorappan; Ramadasan Kuttan
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

View more
  23 in total

1.  The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells.

Authors:  Jin-Jian Lu; Yu-Jun Cai; Jian Ding
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells.

Authors:  Kiran Kumar Naidu Guturi; Tapashi Mandal; Anirban Chatterjee; Moumita Sarkar; Seemana Bhattacharya; Uttara Chatterjee; Mrinal K Ghosh
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

4.  Cytotoxic, chemosensitizing and radiosensitizing effects of curcumin based on thioredoxin system inhibition in breast cancer cells: 2D vs. 3D cell culture system.

Authors:  Shaymaa Essam El Feky; Magda Abdel Ghany Megahed; Nadia Ahmed Abd El Moneim; Ebtsam Rizq Zaher; Shadwa Ahmed Khamis; Lamiaa Mohamed Ahmed Ali
Journal:  Exp Ther Med       Date:  2021-03-18       Impact factor: 2.447

5.  Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells.

Authors:  Jin-Jian Lu; Yu-Jun Cai; Jian Ding
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

6.  Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.

Authors:  Susmita Mondal; Chandan Mandal; Rajender Sangwan; Sarmila Chandra; Chitra Mandal
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

7.  MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.

Authors:  Dewan M S Hossain; Abir K Panda; Sreeparna Chakrabarty; Pushpak Bhattacharjee; Kirti Kajal; Suchismita Mohanty; Irene Sarkar; Diptendra K Sarkar; Santosh K Kar; Gaurisankar Sa
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

8.  Comparison of Anticancer Activity of Dorycnium pentaphyllum Extract on MCF-7 and MCF-12A Cell Line: Correlation with Invasion and Adhesion.

Authors:  Gözde Koygun; Emine Arslan; Gökhan Zengin; Giustino Orlando; Claudio Ferrante
Journal:  Biomolecules       Date:  2021-04-30

9.  Multi-target drugs: the trend of drug research and development.

Authors:  Jin-Jian Lu; Wei Pan; Yuan-Jia Hu; Yi-Tao Wang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Molecular changes induced by the curcumin analogue D6 in human melanoma cells.

Authors:  Carla Rozzo; Manuela Fanciulli; Cristina Fraumene; Antonio Corrias; Tiziana Cubeddu; Ilaria Sassu; Sara Cossu; Valentina Nieddu; Grazia Galleri; Emanuela Azara; Maria Antonietta Dettori; Davide Fabbri; Giuseppe Palmieri; Marina Pisano
Journal:  Mol Cancer       Date:  2013-05-04       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.